Literature DB >> 24768326

Technical details and clinical outcomes of transpopliteal venous stent placement for postthrombotic chronic total occlusion of the iliofemoral vein.

Kaichuang Ye1, Xinwu Lu1, Mi'er Jiang2, Xinrui Yang1, Weimin Li1, Ying Huang1, Xintian Huang1, Min Lu1.   

Abstract

PURPOSE: To evaluate the technical aspects and early clinical results of stent placement for managing postthrombotic chronic total occlusion (CTO) of the iliofemoral vein through ipsilateral popliteal access.
MATERIALS AND METHODS: A retrospective analysis of 110 patients (44 men; mean age, 51 y; 118 limbs; 102 left limbs) with postthrombotic CTO of the iliofemoral vein treated with stent placement in a single institution from January 2007-December 2011 was conducted. All occlusions were initially accessed via ipsilateral popliteal veins under the guidance of venography or ultrasonography. Technical aspects, quality of life, stent patency, and Villalta scores were recorded at follow-up evaluation. Risk factors of in-stent restenosis and early in-stent thrombosis were evaluated using Cox proportional hazards regression model.
RESULTS: Percutaneous recanalization was successful in 112 of 118 limbs (95%). The mean duration of the procedure was 43 minutes (range, 10-120 min). The quality of life and Villalta scores were significantly improved (P < .01). The 3-year primary, assisted primary, and secondary cumulative stent patency rates were 70%, 90%, and 94%. During a median follow-up period of 25 months (range, 1-52 mo), the relief rates of severe leg pain (visual analog scale > 5) and severe leg swelling (grade 3) were 72% (49 of 68) and 70% (64 of 91), respectively, and the healing of ulcers was successful in 78% (36 of 46) of the cases. After stent placement, the limbs with visible remaining collateral circulation had a higher rate of early in-stent thrombosis (22.5% vs 6.1%; P = .007). The patients with long stents extending below the inguinal ligament had a higher rate of in-stent restenosis (hazard ratio = 1.77-6.5; P = .0146).
CONCLUSIONS: Transpopliteal venous stent placement is an effective, safe, and feasible method of managing postthrombotic CTO of the iliofemoral vein. The stent extending below the inguinal ligament is the major risk factor of in-stent restenosis. The visible remaining collateral circulation after stent placement may indicate persistent hemodynamically significant stenosis.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24768326     DOI: 10.1016/j.jvir.2014.02.031

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

1.  Endovascular stent placement for chronic post-thrombotic symptomatic ilio-femoral venous obstructive lesions: a single-center study of safety, efficacy and quality-of-life improvement.

Authors:  Marie-Tiphaine Falcoz; Nicolas Falvo; Serge Aho-Glélé; Emmanuel Demaistre; Christophe Galland; Sylvain Favelier; Pierre Pottecher; Olivier Chevallier; Bernard Bonnotte; Sylvain Audia; Maxime Samson; Béatrice Terriat; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2016-08

2.  Investigation of adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents in the iliac vein: insights into developing a better iliac vein stent.

Authors:  Takuya Shida; Mitsuo Umezu; Kiyotaka Iwasaki
Journal:  J Artif Organs       Date:  2018-02-06       Impact factor: 1.731

3.  Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV).

Authors:  Arthur David; Frédéric Thony; Costantino Del Giudice; Gilles Goyault; Romaric Loffroy; Kévin Guillen; Yann Le Bras; Clément Marcelin; Valérie Monnin-Bares; Jean-François Heautot; Alexandre Lablee; Pierre Marek; Hervé Rousseau; Thomas Martinelli; Francine Thouveny; Pierre-Antoine Barral; Vincent Le Pennec; Pascal Chabrot; André Rogopoulos; Alicia Guillien; Marc Sapoval; Matthieu Rodière; Olivier Espitia; Frédéric Douane
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-04       Impact factor: 2.740

4.  Doppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting.

Authors:  Hong Liu; Jing Wang; Yu Zhao; Zheng Chen; Dong Wang; Miao Wei; Fajin Lv; Xiaoping Ye
Journal:  BMC Cardiovasc Disord       Date:  2021-01-20       Impact factor: 2.298

5.  Three-Year Results from the Venovo Venous Stent Study for the Treatment of Iliac and Femoral Vein Obstruction.

Authors:  Michael D Dake; Gerard O'Sullivan; Nicolas W Shammas; Michael Lichtenberg; Bibombe P Mwipatayi; Richard A Settlage
Journal:  Cardiovasc Intervent Radiol       Date:  2021-09-20       Impact factor: 2.740

6.  A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.

Authors:  Ghulam M Majeed; Krishan Lodhia; Jemima Carter; Jack Kingdon; Rachael I Morris; Adam Gwozdz; Athanasios Saratzis; Prakash Saha
Journal:  J Endovasc Ther       Date:  2021-11-10       Impact factor: 3.089

7.  Stent patency rates and prognostic factors of endovascular intervention for iliofemoral vein occlusion in post-thrombotic syndrome.

Authors:  Rencong Chen; Ruijia Feng; Suiting Jiang; Guangqi Chang; Zuojun Hu; Chen Yao; Benyuan Jia; Shenming Wang; Siwen Wang
Journal:  BMC Surg       Date:  2022-07-12       Impact factor: 2.030

8.  Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review.

Authors:  Pascale Notten; Hugo Ten Cate; Arina J Ten Cate-Hoek
Journal:  J Thromb Haemost       Date:  2021-01-05       Impact factor: 5.824

9.  Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction.

Authors:  Erin Murphy; Kathleen Gibson; Marc Sapoval; David J Dexter; Raghu Kolluri; Mahmood Razavi; Stephen Black
Journal:  Circ Cardiovasc Interv       Date:  2022-02-02       Impact factor: 6.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.